Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials

Immune thrombocytopenic purpura (ITP) is an acquired antibody or cell-mediated platelet damage or decreased platelet production. Steroids, IV immunoglobulins (IVIG), and Rho-anti-D antibodies are the commonly used initial treatments for ITP. However, many ITP patients either do not respond or do not...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Muhammad Ashar, Anwar, Muhammad Yasir, Aiman, Wajeeha, Dhanesar, Gurneel, Omar, Zainab, Hamza, Mohammad, Zafar, Maha, Rengarajan, Harish Kumar, Maroules, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944448/
https://www.ncbi.nlm.nih.gov/pubmed/36810430
http://dx.doi.org/10.3390/jox13010005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944448/
https://www.ncbi.nlm.nih.gov/pubmed/36810430
http://dx.doi.org/10.3390/jox13010005

Ejemplares similares